Loading stock data…
Privia Health Group (PRVA)
$25.50+0.53 (+2.12%)
Market ClosedLast close Jul 24
Privia Health Group, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Privia Health Group, Inc. in the Healthcare sector is trading at $25.50 with a market capitalization of $3.0B. Wall Street consensus targets $31.89 (19 analysts), implying a +25.1% move over the next 12 months. The stock is currently 12% below its 52-week high of $28.82, remaining 7.8% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +25.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 34) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $603.85M↑ | $541.17M↓ | $580.42M↑ | $521.15M↑ | $480.10M |
| Gross Profit | $60.31M↑ | $49.66M↓ | $63.77M↑ | $50.24M↑ | $45.76M |
| Operating Income | $7.42M↓ | $11.28M↓ | $14.40M↑ | $3.34M↓ | $5.22M |
| Net Income | $3.06M↓ | $9.15M↑ | $6.86M↑ | $2.69M↓ | $4.22M |
Peer Comparison
JNJUNHPFE
Fundamentals
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.97B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.89%
Volume
Today's trading volume
878,089
Recent News
3 Reasons to Avoid PRVA and 1 Stock to Buy Instead
Since January 2026, Privia Health has been in a holding pattern, posting a small return of 3.6% while floating around $24.97.
1 Cash-Heavy Stock to Target This Week and 2 We Ignore
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
3 Small-Cap Stocks with Open Questions
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors?
This healthcare services provider, focused on value-based care, reported a notable insider sale amid a year of double-digit stock gains.
3 Cash-Producing Stocks with Open Questions
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.